Friday 6 November 2026 Export AXGN’s income statement to Excel — free account

AxoGen, Inc.

AXGN Healthcare Medical Devices

AxoGen, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $225.2 million, up 20.2% from fiscal 2024.

Revenue: +26.2%
EPS: +163.2%
Free cash flow: +995.0%
Total debt: −73.1%

Quarter to September 2026, against a year earlier

Revenue growth 10 yrs

49.43 0.68 +1.39%

Follow AXGN

Alert me

Market cap: $2.9B
P/E: 0.0×
Fwd P/E: −129×
Dividend yield: —
F-score: 5/9
Altman Z: 9.23
Beneish M: −2.73
Dividend safety: n/a

Overview

AxoGen, Inc. (AXGN) P/S ratio

Alert me on P/S ratio

As of 5 November 2026, AxoGen, Inc. (AXGN) trades at a P/S ratio of 10.1×. Over the past ten years it has ranged from 1.0× (November 2023) to 28.9× (July 2018); the current reading is higher than 86% of that period. That is above the Medical Devices industry median of 2.5× and above the Healthcare sector median of 3.5×.

Embed this chart

Code for your page

<iframe src="https://stockrow.com/embed/AXGN/ps-ratio" width="100%" height="360" style="border:0" loading="lazy" title="AxoGen, Inc. P/S ratio, 10 years"></iframe>
<p style="font-size:12px">Source: <a href="https://stockrow.com/AXGN/metrics/ps-ratio">AxoGen, Inc. (AXGN) P/S ratio — stockrow.com</a></p>

Period	P/S ratio	Change
FY2025	6.7×	71.90%
FY2024	3.9×	108.95%
FY2023	1.9×	(37.89%)
FY2022	3.0×	(1.06%)
FY2021	3.0×	(52.40%)
FY2020	6.4×	(3.15%)
FY2019	6.6×	(27.21%)
FY2018	9.0×	(41.37%)
FY2017	15.4×	131.88%
FY2016	6.6×	39.34%

Period	P/S ratio	Change
Sep 2026	8.7×	(11.69%)
Jun 2026	9.8×	36.64%
Mar 2026	7.2×	7.26%
Dec 2025	6.7×	73.24%
43 more quarters	Free account

Against its own ten years

Low 1.0× High 28.9×

Ten-year median 5.1×

Current reading's percentile 84

Company	P/S ratio
INSP Inspire Medical Systems, Inc. compare	2.2×
ITGR Integer Holdings Corporation compare	2.4×
NEOG Neogen Corporation compare	2.9×
TMDX TransMedics Group, Inc. compare	3.3×
UFPT UFP Technologies, Inc. compare	3.6×
IRTC iRhythm Holdings, Inc. compare	5.1×
ESTA Establishment Labs Holdings Inc. compare	7.9×
AXGN AxoGen, Inc.	10.1×
ALMR Alamar Biosciences, Inc. compare	17.8×
Medical Devices industry median	2.5×
Healthcare sector median	3.5×
Market median	1.9×

What P/S ratio is

Price to Sales Ratio shows how much investors pay for each dollar of a company’s annual sales, whether or not it is profitable.

(Stock Price × Shares (Basic, Weighted) (latest quarter)) ÷ Revenue (TTM)

The full definition of P/S ratio →

AxoGen, Inc. (AXGN) P/S ratio

P/S ratio, daily

Annual newest first

Quarterly newest first

Against its own ten years

P/S ratio against peers

What P/S ratio is

More on AXGN

P/S ratio, daily

Annual newest first

Quarterly newest first

Against its own ten years

P/S ratio against peers

What P/S ratio is

More on AXGN

Stockrow Weekly